BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 33805904)

  • 1. MAIT Cells: Partners or Enemies in Cancer Immunotherapy?
    Cogswell DT; Gapin L; Tobin HM; McCarter MD; Tobin RP
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33805904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human MAIT cells endowed with HBV specificity are cytotoxic and migrate towards HBV-HCC while retaining antimicrobial functions.
    Healy K; Pavesi A; Parrot T; Sobkowiak MJ; Reinsbach SE; Davanian H; Tan AT; Aleman S; Sandberg JK; Bertoletti A; Sällberg Chen M
    JHEP Rep; 2021 Aug; 3(4):100318. PubMed ID: 34377970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular basis for Mucosal-Associated Invariant T cell recognition of MR1 proteins.
    López-Sagaseta J; Dulberger CL; Crooks JE; Parks CD; Luoma AM; McFedries A; Van Rhijn I; Saghatelian A; Adams EJ
    Proc Natl Acad Sci U S A; 2013 May; 110(19):E1771-8. PubMed ID: 23613577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal-associated invariant T cells for cancer immunotherapy.
    Li YR; Zhou K; Wilson M; Kramer A; Zhu Y; Dawson N; Yang L
    Mol Ther; 2023 Mar; 31(3):631-646. PubMed ID: 36463401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells.
    Eckle SB; Birkinshaw RW; Kostenko L; Corbett AJ; McWilliam HE; Reantragoon R; Chen Z; Gherardin NA; Beddoe T; Liu L; Patel O; Meehan B; Fairlie DP; Villadangos JA; Godfrey DI; Kjer-Nielsen L; McCluskey J; Rossjohn J
    J Exp Med; 2014 Jul; 211(8):1585-600. PubMed ID: 25049336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Human Mucosal-associated Invariant T (MAIT) Cells.
    Souter MNT; Loh L; Li S; Meehan BS; Gherardin NA; Godfrey DI; Rossjohn J; Fairlie DP; Kedzierska K; Pellicci DG; Chen Z; Kjer-Nielsen L; Corbett AJ; McCluskey J; Eckle SBG
    Curr Protoc Immunol; 2019 Dec; 127(1):e90. PubMed ID: 31763790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights Into Mucosal-Associated Invariant T Cell Biology From Studies of Invariant Natural Killer T Cells.
    Garner LC; Klenerman P; Provine NM
    Front Immunol; 2018; 9():1478. PubMed ID: 30013556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAIT, MR1, microbes and riboflavin: a paradigm for the co-evolution of invariant TCRs and restricting MHCI-like molecules?
    Mondot S; Boudinot P; Lantz O
    Immunogenetics; 2016 Aug; 68(8):537-48. PubMed ID: 27393664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAIT cell-MR1 reactivity is highly conserved across multiple divergent species.
    Edmans MD; Connelley TK; Morgan S; Pediongco TJ; Jayaraman S; Juno JA; Meehan BS; Dewar PM; Maze EA; Roos EO; Paudyal B; Mak JYW; Liu L; Fairlie DP; Wang H; Corbett AJ; McCluskey J; Benedictus L; Tchilian E; Klenerman P; Eckle SBG
    J Biol Chem; 2024 May; 300(6):107338. PubMed ID: 38705391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen Recognition by MR1-Reactive T Cells; MAIT Cells, Metabolites, and Remaining Mysteries.
    Corbett AJ; Awad W; Wang H; Chen Z
    Front Immunol; 2020; 11():1961. PubMed ID: 32973800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Mucosal Associated Invariant T Cells in Antimicrobial Immunity.
    Napier RJ; Adams EJ; Gold MC; Lewinsohn DM
    Front Immunol; 2015; 6():344. PubMed ID: 26217338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAIT Cells Come to the Rescue in Cancer Immunotherapy?
    Lukasik Z; Elewaut D; Venken K
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32053875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor.
    Reantragoon R; Kjer-Nielsen L; Patel O; Chen Z; Illing PT; Bhati M; Kostenko L; Bharadwaj M; Meehan B; Hansen TH; Godfrey DI; Rossjohn J; McCluskey J
    J Exp Med; 2012 Apr; 209(4):761-74. PubMed ID: 22412157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells.
    Reantragoon R; Corbett AJ; Sakala IG; Gherardin NA; Furness JB; Chen Z; Eckle SB; Uldrich AP; Birkinshaw RW; Patel O; Kostenko L; Meehan B; Kedzierska K; Liu L; Fairlie DP; Hansen TH; Godfrey DI; Rossjohn J; McCluskey J; Kjer-Nielsen L
    J Exp Med; 2013 Oct; 210(11):2305-20. PubMed ID: 24101382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal-associated invariant T (MAIT) cells, a new source of universal immune cells for chimeric antigen receptor (CAR)-cell therapy.
    Bohineust A; Tourret M; Derivry L; Caillat-Zucman S
    Bull Cancer; 2021 Oct; 108(10S):S92-S95. PubMed ID: 34920812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MHC class I-related molecule, MR1, and mucosal-associated invariant T cells.
    Franciszkiewicz K; Salou M; Legoux F; Zhou Q; Cui Y; Bessoles S; Lantz O
    Immunol Rev; 2016 Jul; 272(1):120-38. PubMed ID: 27319347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Heterogeneity and Antimycobacterial Effects of Mouse Mucosal-Associated Invariant T Cells Specific for Riboflavin Metabolites.
    Sakala IG; Kjer-Nielsen L; Eickhoff CS; Wang X; Blazevic A; Liu L; Fairlie DP; Rossjohn J; McCluskey J; Fremont DH; Hansen TH; Hoft DF
    J Immunol; 2015 Jul; 195(2):587-601. PubMed ID: 26063000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human liver CD8
    Rha MS; Han JW; Kim JH; Koh JY; Park HJ; Kim SI; Kim MS; Lee JG; Lee HW; Lee DH; Kim W; Park JY; Joo DJ; Park SH; Shin EC
    J Hepatol; 2020 Sep; 73(3):640-650. PubMed ID: 32247824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservation of mucosal associated invariant T (MAIT) cells and the MR1 restriction element in ruminants, and abundance of MAIT cells in spleen.
    Goldfinch N; Reinink P; Connelley T; Koets A; Morrison I; Van Rhijn I
    Vet Res; 2010; 41(5):62. PubMed ID: 20507818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal-Associated Invariant T (MAIT) Cell Dysfunction and PD-1 Expression in Prostate Cancer: Implications for Immunotherapy.
    Jarvis EM; Collings S; Authier-Hall A; Dasyam N; Luey B; Nacey J; Painter GF; Delahunt B; Hermans IF; Weinkove R
    Front Immunol; 2021; 12():748741. PubMed ID: 34737749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.